89 related articles for article (PubMed ID: 2719740)
1. Effect of heparin-like compounds on the in vitro proliferation and protein synthesis of various cell types.
Tiozzo R; Cingi MR; Pietrangelo A; Albertazzi L; Calandra S; Milani MR
Arzneimittelforschung; 1989 Jan; 39(1):15-20. PubMed ID: 2719740
[TBL] [Abstract][Full Text] [Related]
2. Effect of heparin on cell proliferation: lack of correlation with heparin binding sites on cell membrane.
Tiozzo R; Reggiani D; Croce MA; Calandra S; Osima B; Bianchini P
Drugs Exp Clin Res; 1997; 23(3-4):103-9. PubMed ID: 9403270
[TBL] [Abstract][Full Text] [Related]
3. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment.
Bârzu T; Herbert JM; Desmoulière A; Carayon P; Pascal M
J Cell Physiol; 1994 Aug; 160(2):239-48. PubMed ID: 8040184
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
5. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
6. Effect of heparin on vascular smooth muscle cells. I. Cell metabolism.
Castellot JJ; Cochran DL; Karnovsky MJ
J Cell Physiol; 1985 Jul; 124(1):21-8. PubMed ID: 4044651
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.
Majack RA; Clowes AW
J Cell Physiol; 1984 Mar; 118(3):253-6. PubMed ID: 6699099
[TBL] [Abstract][Full Text] [Related]
8. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
9. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
10. Effects of heparinoids on the sclerotic reaction of rat thoracic aorta to injury: comparison between standard and low-molecular-weight heparins in vitro and in vivo.
Chajara A; Heudes D; Peronneau I; Jarnet J; Basset A; Capron L
J Cardiovasc Pharmacol; 1994 Jun; 23(6):995-1003. PubMed ID: 7523793
[TBL] [Abstract][Full Text] [Related]
11. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor.
Reilly CF; Fritze LM; Rosenberg RD
J Cell Physiol; 1987 May; 131(2):149-57. PubMed ID: 3495540
[TBL] [Abstract][Full Text] [Related]
13. Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin.
Caleb BL; Hardenbrook M; Cherington V; Castellot JJ
J Cell Physiol; 1996 May; 167(2):185-95. PubMed ID: 8613458
[TBL] [Abstract][Full Text] [Related]
14. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin.
Orlandi A; Ropraz P; Gabbiani G
Exp Cell Res; 1994 Oct; 214(2):528-36. PubMed ID: 7925646
[TBL] [Abstract][Full Text] [Related]
15. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.
Benezra M; Vogel T; Ben-Sasson SA; Panet A; Sehayek E; Al-Haideiri M; Decklbaum RJ; Vlodavsky I
J Cell Biochem; 2001; 81(1):114-27. PubMed ID: 11180402
[TBL] [Abstract][Full Text] [Related]
16. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin.
Clowes AW; Clowes MM
Lab Invest; 1985 Jun; 52(6):611-6. PubMed ID: 4040189
[TBL] [Abstract][Full Text] [Related]
18. Pericyte growth and contractile phenotype: modulation by endothelial-synthesized matrix and comparison with aortic smooth muscle.
Newcomb PM; Herman IM
J Cell Physiol; 1993 May; 155(2):385-93. PubMed ID: 8482730
[TBL] [Abstract][Full Text] [Related]
19. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures.
Bârzu T; Pascal M; Maman M; Roque C; Lafont F; Rousselet A
J Cell Physiol; 1996 Apr; 167(1):8-21. PubMed ID: 8698843
[TBL] [Abstract][Full Text] [Related]
20. Unfractionated heparin and low molecular weight heparin do not inhibit the growth of proliferating human arterial smooth muscle cells in culture.
Stavenow L; Lindblad B; Xu CB
Eur J Vasc Endovasc Surg; 1995 Aug; 10(2):215-9. PubMed ID: 7655975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
